MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-22-2026
Quest Diagnostics Incorporated Operating Cycle 2011-2026 | DGX
Annual Operating Cycle Quest Diagnostics Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54.2 | 56.9 | 58.7 | 59.9 | 62 | 60.8 | 59.1 | 56.4 | 51.1 | 51.5 | 50.5 | 54.4 | 51.2 | 50.6 | 51.5 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 62 | 50.5 | 55.3 |
Quarterly Operating Cycle Quest Diagnostics Incorporated
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 57.6 | 55.7 | 56.1 | 57.3 | 59.4 | 60.7 | 60.6 | 60.9 | 59.6 | 59.1 | - | 28.6 | 31.1 | 60.3 | - | 55.9 | 59.5 | 61.2 | 46.2 | 62.7 | 92.6 | 77.1 | 50.4 | 58.5 | 58.5 | 58.2 | 50.2 | 56.3 | 55.4 | 54.1 | 45.2 | 52.7 | 52.6 | 53.4 | 45.4 | 51.3 | 50.8 | 51.4 | 44.5 | 50.3 | 49.2 | 53.1 | 45.2 | 53.2 | 53.3 | 55 | 44.3 | 51.1 | 50.4 | 51.6 | 44.6 | 51.3 | 49.8 | 49.9 | 44.8 | 50.7 | 50.8 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 92.6 | 28.6 | 53.6 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
275 | $ 17.56 | -5.39 % | $ 186 M |  China |
 |
Co-Diagnostics
CODX
|
1.79 K | $ 1.46 | -10.44 % | $ 1.94 M |  USA |
 |
Agilent Technologies
A
|
161 | $ 112.25 | -0.88 % | $ 34.1 B | USA |
 |
Castle Biosciences
CSTL
|
97.4 | $ 18.84 | -0.21 % | $ 546 M | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 16.07 | -0.74 % | $ 486 M | USA |
 |
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
198 | $ 140.65 | -1.81 % | $ 22.4 B | USA |
 |
Interpace Biosciences
IDXG
|
96 | $ 1.8 | -5.26 % | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 20.22 | -1.32 % | $ 1.08 B | USA |
 |
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
121 | $ 94.75 | -1.99 % | $ 6.39 B | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 418.79 | -0.09 % | $ 12.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | China |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 047.48 | 0.53 % | $ 21.6 B |  Schweiz |
 |
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B |  Australia |
 |
Myriad Genetics
MYGN
|
95.1 | $ 3.63 | 0.14 % | $ 336 M | USA |
 |
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | China |
 |
NeoGenomics
NEO
|
102 | $ 8.26 | -1.2 % | $ 1.06 B | USA |
 |
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
29.4 | $ 18.68 | -1.32 % | $ 418 M | USA |
 |
Natera
NTRA
|
81.5 | $ 188.85 | -4.1 % | $ 18.6 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 159.21 | 0.06 % | $ 7.89 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 25.26 | -0.94 % | $ 24 B |  Niderland |
 |
Guardant Health
GH
|
128 | $ 96.67 | -2.02 % | $ 12.1 B | USA |
 |
Personalis
PSNL
|
63.8 | $ 6.5 | -3.13 % | $ 580 M | USA |
 |
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 118.02 | 0.79 % | $ 9.73 B |  Irlanda |
 |
Senseonics Holdings
SENS
|
104 | $ 5.86 | 0.6 % | $ 245 M | USA |
 |
Soleno Therapeutics
SLNO
|
1.04 K | $ 52.98 | -0.02 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
204 | $ 2.31 | -4.04 % | $ 5.31 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 251.49 | -1.03 % | $ 20.9 B | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 441.01 | -1.61 % | $ 166 B | USA |
 |
Trinity Biotech plc
TRIB
|
299 | $ 0.6 | 3.48 % | $ 216 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
 |
Twist Bioscience Corporation
TWST
|
96.1 | $ 49.96 | -5.65 % | $ 2.99 B | USA |
 |
Neogen Corporation
NEOG
|
213 | $ 8.35 | -1.01 % | $ 1.81 B | USA |